Accordingly, upregulation of these regulatory immune subtypes was associated with lower levels of proinflammatory cytokines (Fig. 4B–E), in particular IL-6 and IL-1β, in the blood of treated severe COVID-19 patients (Fig. 4B,E). This evidence concerns the gene IL1B and COVID-19.